Corrigendum to "Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model" [Metab Clin Exp 119 (2021) 154749 1-14 [METABOLISM-D-20-01502R3]]. — SciRadar